title: Adjuvant-induced macrophage-dominant nephrotoxic serum nephritis in rats.
abstract: BACKGROUND
  To investigate cellular mechanisms responsible for the development of crescentic glomerular lesions, we have studied the effects of complete adjuvant (CA) on subnephritogenic nephrotoxic serum (NTS) nephritis (NTS-N) in Brown Norway rats.
  
  
  METHODS
  A subnephritogenic dose of NTS, 0.02 ml per rat, was intravenously injected into rats that were previously (14 days earlier) treated intradermally with CA, incomplete adjuvant, or PBS.
  
  
  RESULTS
  Proteinuria developed by day 2 only in CA-treated rats. Also, severe glomerular lesions associated with cellular crescent formation developed by day 2 only in the CA-treated rats. The glomerular extent of infiltration of IL-1beta-positive cells, MCP-1 expression level, and the number of ED1 and PCNA double-positive activated macrophages peaked on day 4 and decreased thereafter. The numbers of T lymphocytes and polymorphonuclear neutrophils did not significantly increase throughout the experiments.
  
  
  CONCLUSIONS
  These results indicate that CA can potently induce crescentic NTS-N characterized by the infiltration of activated macrophages, which presumably bind to rabbit IgG on the glomerular basement membrane and may play a critical role in the development of severe NTS-N associated with crescent formation.
authors.affiliation: Department of Nephrology, Showa University School of Medicine, 1-5-8 Hatanodai, Tokyo 142-8666, Japan. mukai13@med.showa-u.ac.jp
authors.forename: Kazumitsu
authors.initials: K
authors.lastname: Mukai
authors.forename: Takanori
authors.initials: T
authors.lastname: Shibata
authors.forename: Kenichi
authors.initials: K
authors.lastname: Kato
authors.forename: Tetsuzo
authors.initials: T
authors.lastname: Sugisaki
mesh_terms: D000818:Animals; D000906:Antibodies / Q000276:immunology*; D001323:Autoantibodies; D018932:Chemokine CCL2 / Q000378:metabolism; D053331:Ectodysplasins; D005260:Female; D005455:Fluorescent Antibody Technique; D005620:Freund's Adjuvant / Q000276:immunology*; D007106:Immune Sera / Q000276:immunology*; D007150:Immunohistochemistry / Q000379:methods; D007375:Interleukin-1 / Q000378:metabolism; D007678:Kidney Glomerulus / Q000378:metabolism / Q000473:pathology; D008264:Macrophages / Q000378:metabolism / Q000473:pathology*; D008565:Membrane Proteins / Q000378:metabolism; D009393:Nephritis / Q000276:immunology* / Q000378:metabolism / Q000473:pathology*; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism; D011507:Proteinuria / Q000276:immunology; D051381:Rats; D011914:Rats, Inbred BN; D013194:Staining and Labeling; D013997:Time Factors
chemical_list: D000906:Antibodies; D001323:Autoantibodies; C491766:Ccl2 protein, rat; D018932:Chemokine CCL2; D053331:Ectodysplasins; D007106:Immune Sera; D007375:Interleukin-1; D008565:Membrane Proteins; D018809:Proliferating Cell Nuclear Antigen; C051951:antiglomerular basement membrane antibody; D005620:Freund's Adjuvant